statistiche ricercatore

Continente	#
NA - Nord America	2.045
EU - Europa	630
AS - Asia	603
Continente sconosciuto - Info sul continente non disponibili	129
SA - Sud America	96
AF - Africa	22
OC - Oceania	4
Totale	3.529

Nazione	#
US - Stati Uniti d'America	2.014
SG - Singapore	224
RU - Federazione Russa	196
CN - Cina	154
IT - Italia	124
BR - Brasile	78
FI - Finlandia	71
DE - Germania	51
HK - Hong Kong	49
VN - Vietnam	46
GB - Regno Unito	37
PL - Polonia	30
IN - India	24
FR - Francia	23
IE - Irlanda	20
BE - Belgio	17
CA - Canada	17
BD - Bangladesh	16
JP - Giappone	16
KR - Corea	16
EG - Egitto	11
SE - Svezia	11
MY - Malesia	9
PK - Pakistan	8
RO - Romania	8
TR - Turchia	8
ES - Italia	7
NL - Olanda	7
AT - Austria	6
CH - Svizzera	5
IQ - Iraq	5
VE - Venezuela	5
AR - Argentina	4
AU - Australia	4
CR - Costa Rica	4
MX - Messico	4
PH - Filippine	4
AL - Albania	3
CL - Cile	3
IR - Iran	3
KE - Kenya	3
PT - Portogallo	3
SA - Arabia Saudita	3
UA - Ucraina	3
ZA - Sudafrica	3
CI - Costa d'Avorio	2
EC - Ecuador	2
ID - Indonesia	2
LB - Libano	2
LT - Lituania	2
MA - Marocco	2
MO - Macao, regione amministrativa speciale della Cina	2
OM - Oman	2
SI - Slovenia	2
AZ - Azerbaigian	1
BO - Bolivia	1
CO - Colombia	1
CZ - Repubblica Ceca	1
EE - Estonia	1
EU - Europa	1
GE - Georgia	1
GH - Ghana	1
HN - Honduras	1
IL - Israele	1
JM - Giamaica	1
KG - Kirghizistan	1
KW - Kuwait	1
KY - Cayman, isole	1
KZ - Kazakistan	1
MD - Moldavia	1
MM - Myanmar	1
MN - Mongolia	1
NI - Nicaragua	1
PE - Perù	1
QA - Qatar	1
RS - Serbia	1
SV - El Salvador	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	3.401

Nome	#
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines	339
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors	310
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma	287
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis	283
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors	276
Targeted Therapies in Hepatocellular Carcinoma	272
Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility	272
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment	269
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy	244
Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience	243
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer	240
Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond	195
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers	183
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis	116
Totale	3.529

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	146	0	0	0	7	5	15	12	21	22	20	14	30
2022/2023	266	27	49	7	33	24	42	27	25	20	2	10	0
2023/2024	143	5	16	11	27	11	32	12	4	0	3	4	18
2024/2025	334	3	9	9	27	17	13	27	33	22	33	66	75
2025/2026	1.084	99	30	57	74	126	177	163	101	76	96	36	49
2026/2027	216	61	27	126	2	0	0	0	0	0	0	0	0
Totale													3.529

Archivio istituzionale della ricerca dell'Università degli Studi di Palermo